Emerging hepatitis B virus infection in vaccinated populations: a rising concern?

References

• Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis2002; 2: 395–403.
   PubMed Web of Science ®Google Scholar
• Beasley RP, Hwang LY, Lee GC et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet1983; 2: 1099–1102.
   PubMed Web of Science ®Google Scholar
• Lo KJ, Tsai YT, Lee SD et al. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis1985; 152: 817–822.
   PubMed Web of Science ®Google Scholar
• Hsu HM, Chen DS, Chuang CH et al. Efficacy of a mass hepatitis B vaccination program in Taiwan. Studies on 3464 infants of hepatitis B surface antigen-carrier mothers. JAMA1988; 260: 2231–2235.
   PubMed Web of Science ®Google Scholar
• Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol1986; 18: 301–307.
   PubMed Web of Science ®Google Scholar
• Chen HL, Chang MH, Ni YH et al. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA1996; 276: 906–908.
   PubMed Web of Science ®Google Scholar
• Ni YH, Chang MH, Huang LM et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med2001; 135: 796–800.
   PubMed Web of Science ®Google Scholar
• Ni YH, Huang LM, Chang MH et al. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology2007; 132: 1287–1293.
   PubMed Web of Science ®Google Scholar
• Kao JH, Hsu HM, Shau WY, Chang MH, Chen DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr2001; 139: 349–352.
   PubMed Web of Science ®Google Scholar
• Chen HL, Chang CJ, Kong MS et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology2004; 39: 58–63.
   PubMed Web of Science ®Google Scholar
• Chang MH, Chen CJ, Lai MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med1997; 336: 1855–1859.
   PubMed Web of Science ®Google Scholar
• Chang MH, Chen TH, Hsu HM et al. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems. Clin Cancer Res2005; 11: 7953–7957.
   PubMed Web of Science ®Google Scholar
• Chang MH, You SL, Chen CJ et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst2009; 101: 1348–1355.
   PubMed Web of Science ®Google Scholar
• Chen DS. Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B. J Hepatol 2009; 50: 805–816.
   PubMed Web of Science ®Google Scholar
• Marion SA, TommPastore M, Pi DW, Mathias RG. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol1994; 140: 734–746.
   PubMed Web of Science ®Google Scholar
• Sood A, Singh D, Mehta S, Midha V, Kumar R. Response to hepatitis B vaccine in preterm babies. Indian J Gastroenterol2002; 21: 52–54.
   PubMedGoogle Scholar
• Freitas da Motta MS, Mussi-Pinhata MM, Jorge SM, Tachibana Yoshida CF, Sandoval de Souza CB. Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life. Vaccine2002; 20: 1557–1562.
   PubMed Web of Science ®Google Scholar
• Saari TN. Immunization of preterm and low birth weight infants. Pediatrics2003; 112: 193–198.
   PubMed Web of Science ®Google Scholar
• Lee CY, Huang LM, Chang MH et al. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers. Pediatr Infect Dis J1991; 10: 299–303.
   PubMed Web of Science ®Google Scholar
• Hwang LY, Beasley RP, Stevens CE, Szmuness W. Immunogenicity of HBV vaccine in healthy Chinese children. Vaccine1983; 1: 10–12.
   PubMedGoogle Scholar
• Mast EE, Weinbaum CM, Fiore AE et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep2006; 55: 1-33; quiz CE31–34.
   PubMedGoogle Scholar
• Williams IT, Goldstein ST, Tufa J, Tauillii S, Margolis HS, Mahoney FJ. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J2003; 22: 157–163.
   PubMed Web of Science ®Google Scholar
• Lu CY, Chiang BL, Chi WK et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology2004; 40: 1415–1420.
   PubMed Web of Science ®Google Scholar
• Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis2003; 187: 134–138.
   PubMed Web of Science ®Google Scholar
• Stramer SL, Wend U, Candotti D et al. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med2011; 364: 236–247.
   PubMed Web of Science ®Google Scholar
• Liu CJ, Lo SC, Kao JH et al. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol2006; 44: 39–46.
   PubMed Web of Science ®Google Scholar
• Yuan Q, Song LW, Liu CJ et al. Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients. Gut2012 Jun 14. DOI: 10.1136/gutjnl-2012-302656.
   PubMedGoogle Scholar
• West DJ. Clinical experience with hepatitis B vaccines. Am J Infect Control1989; 17: 172–180.
   PubMed Web of Science ®Google Scholar
• West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine1996; 14: 1019–1027.
   PubMed Web of Science ®Google Scholar
• Wismans PJ, van Hattum J, de Gast GC et al. The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen. ClinExpImmunol1989; 78: 75–79.
   Google Scholar
• Zanetti AR, Mariano A, Romano L et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet2005; 366: 1379–1384.
   PubMed Web of Science ®Google Scholar
• Lin CC, Chen CL, Concejero A et al. Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients. Am J Transplant2007; 7: 195–200.
   PubMed Web of Science ®Google Scholar
• Jan CF, Huang KC, Chien YC et al. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology2010; 51: 1547–1554.
   PubMed Web of Science ®Google Scholar
• Goilav C, Piot P. Vaccination against hepatitis B in homosexual men. A review. Am J Med1989; 87: 21S–25S.
   PubMed Web of Science ®Google Scholar